Premium
The dual thromboxane receptor antagonist and thromboxane synthase inhibitor EV‐077 is a more potent inhibitor of platelet function than aspirin
Author(s) -
FONTANA P.,
ALBERTS P.,
SAKARIASSEN K. S.,
BOUNAMEAUX H.,
MEYER J.P.,
SANTANA SORENSEN A.
Publication year - 2011
Publication title -
journal of thrombosis and haemostasis
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.947
H-Index - 178
eISSN - 1538-7836
pISSN - 1538-7933
DOI - 10.1111/j.1538-7836.2011.04446.x
Subject(s) - thromboxane a synthase , thromboxane a2 , chemistry , platelet , pharmacology , thromboxane receptor , receptor antagonist , receptor , thromboxane , platelet activation , antagonist , platelet aggregation inhibitor , arachidonic acid , aspirin , medicine , biochemistry , biology , enzyme